It has also been demonstrated that cytokine blockade with anti-TNF-α monoclonal antibody can decrease the incidence of BT in cirrhotic rats with ascites [32], and the integrity of intestinal barrier can be preserved in the IL-6 knockout mice [33]. This evidence concerns the gene TNF and Ascites.